Respiratory infections rather than antibiotics may increase clozapine levels: a critical review of the literature.
Jose
J
de Leon
D000900:Anti-Bacterial Agents / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000097:blood* / Q000493:pharmacokinetics / Q000627:therapeutic use; D003024:Clozapine / Q000097:blood* / Q000493:pharmacokinetics / Q000627:therapeutic use; D015897:Comorbidity; D019388:Cytochrome P-450 CYP1A2 / Q000378:metabolism; D065609:Cytochrome P-450 CYP1A2 Inhibitors; D004334:Drug Administration Schedule; D004347:Drug Interactions; D006801:Humans; D001523:Mental Disorders / Q000188:drug therapy / Q000453:epidemiology / Q000378:metabolism; D012141:Respiratory Tract Infections / Q000188:drug therapy / Q000453:epidemiology / Q000378:metabolism*
D000900:Anti-Bacterial Agents; D014150:Antipsychotic Agents; D065609:Cytochrome P-450 CYP1A2 Inhibitors; D019388:Cytochrome P-450 CYP1A2; D003024:Clozapine